Aldeyra Therapeutics Inc (ALDX) Price Prediction & ForecastALDXAldeyra Therapeutics Inc

Alphio's ALDX stock price prediction model matches the current Aldeyra Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.46 (-1.37%). The 1-week path is $1.42 (-4.18%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Aldeyra Therapeutics is not a good buy right now. The current price is $1.485, which is significantly lower than the downgraded analyst price target of $2. Additionally, the stock has experienced a year-to-date change of -68.20%, indicating severe underperformance. The RSI is at 34.952, suggesting that the stock is oversold but may not recover soon due to the recent FDA rejection of its dry eye treatment, which has led to a 75% drop in stock value. The main risk is the company's negative net income, which was -$5,450,273 in Q2 2026, reflecting ongoing financial struggles that could hinder recovery efforts.

Aldeyra Therapeutics Inc (ALDX) last closed at $1.485, losing -3.57%. These facts feed the 1-day and 1-week ALDX price prediction above.